Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hoshi Iryo-Sanki Co's Total Liabilities for the quarter that ended in Mar. 2026 was 円6,418 Mil.
Hoshi Iryo-Sanki Co's quarterly Total Liabilities
increased
from Sep. 2025 (円5,922.88 Mil) to Dec. 2025 (円6,171.71 Mil) and
increased
from Dec. 2025 (円6,171.71 Mil) to Mar. 2026 (円6,417.92 Mil).
Hoshi Iryo-Sanki Co's annual Total Liabilities
increased
from Mar. 2024 (円5,664.29 Mil) to Mar. 2025 (円5,874.08 Mil) and
increased
from Mar. 2025 (円5,874.08 Mil) to Mar. 2026 (円6,417.92 Mil).
Hoshi Iryo-Sanki Co Total Liabilities Related Terms
Hoshi Iryo-Sanki Co Total Liabilities Historical Data
* Premium members only.
The historical data trend for Hoshi Iryo-Sanki Co's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Hoshi Iryo-Sanki Co's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hoshi Iryo-Sanki Co (TSE:7634) has a Total Liabilities of 円6,418 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Hoshi Iryo-Sanki Co and its competitors.
Is Hoshi Iryo-Sanki Co's Total Liabilities too high?
Hoshi Iryo-Sanki Co's current Total Liabilities is 円6,418 Mil. Overall, Hoshi Iryo-Sanki Co has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hoshi Iryo-Sanki Co's Total Liabilities compare to MCK and COR?
Hoshi Iryo-Sanki Co's Total Liabilities of 円6,418 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Distribution company?
A good Total Liabilities depends on the Medical Distribution industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Hoshi Iryo-Sanki Co and its competitors. Hoshi Iryo-Sanki Co's current Total Liabilities is 円6,418 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoshi Iryo-Sanki Co stock overvalued right now?
Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co (TSE:7634) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,738.26, compared to a current price of 円5,300.00 — trading 11.9% above its estimated fair value. The current Total Liabilities is 円6,418 Mil. Hoshi Iryo-Sanki Co's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Hoshi Iryo-Sanki Co (TSE:7634), the current Total Liabilities is 円6,418 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hoshi Iryo-Sanki Co (TSE:7634) Overvalued in 2026?
Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co stock appears to be overvalued.
The current stock price of 円5,300.00 is trading 11.9% above its estimated GF Value™ of 円4,738.26.
GuruFocus considers Hoshi Iryo-Sanki Co to be Modestly Overvalued.
Key valuation signals for TSE:7634:
Total Liabilities: 円6,418 Mil
GF Value™: 円4,738.26 vs. price of 円5,300.00 (11.9% above fair value)
No single metric tells the full story. See the TSE:7634 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hoshi Iryo-Sanki Co Ltd is engaged in the manufacturing and sale of pharmaceutical products. The company offers medical oxygen, nitrous oxide, and others. It is also engaged in the planning, manufacture, sale, maintenance, inspection, and repair of medical instrument equipment for medical gas supply facilities. The company's project service includes the production and supply of medical gas, home care, medical gas maintenance, and others.
75GF Score
Get the complete analysis for TSE:7634
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7634 has been successfully added to your 
